You are here

Impact Of Smoking Cessation Treatment Reimbursement On The Quit Rates In Smokers Motivated To Quit

Last updated on March 14, 2019

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Burnaby, British Columbia, V5G 1T4 Canada
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Smoking Cessation, Insurance Coverage
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18-75 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Daily smokers (10 cigarettes per day or more);

- Smokers motivated to make a quit attempt within the next 14 days;

- Potential subjects must be outpatients;

- A subject must have a stable mental and physical medical condition (as per
investigator's judgment).

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- A subject currently eligible for smoking cessation treatment (SCT) reimbursement,
whether from a public or a private drug insurance;

- A subject with an unknown drug insurance status;

- A subject living in a household where there is someone already recruited in the study;

- A subject with an unfilled SCT prescription issued within the past three months or
with an unused SCT product;

- A subject with a life-threatening illness (ie, known or suspected cancer or other
disease with a life expectancy of less than one year).

NCT00818207
Pfizer
Completed
Impact Of Smoking Cessation Treatment Reimbursement On The Quit Rates In Smokers Motivated To Quit

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now